NASDAQ:JAZZ is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.

Last update: Nov 25, 2024

Discover JAZZ PHARMACEUTICALS PLC (NASDAQ:JAZZ)—an undervalued stock our stock screener has picked out. NASDAQ:JAZZ demonstrates solid fundamentals, including health and profitability, all while staying attractively priced. Let's explore the details.

Valuation Examination for NASDAQ:JAZZ

ChartMill provides a Valuation Rating to every stock, ranging from 0 to 10. This rating assesses various valuation aspects, comparing price to earnings and cash flows, while considering factors like profitability and growth. NASDAQ:JAZZ boasts a 9 out of 10:

With a Price/Earnings ratio of 6.46, the valuation of JAZZ can be described as very cheap.
JAZZ's Price/Earnings ratio is rather cheap when compared to the industry. JAZZ is cheaper than 93.23% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 29.29. JAZZ is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 5.72, which indicates a rather cheap valuation of JAZZ.
JAZZ's Price/Forward Earnings ratio is rather cheap when compared to the industry. JAZZ is cheaper than 93.75% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 24.01. JAZZ is valued rather cheaply when compared to this.
Based on the Enterprise Value to EBITDA ratio, JAZZ is valued cheaper than 88.02% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, JAZZ is valued cheaply inside the industry as 94.79% of the companies are valued more expensively.
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
JAZZ has a very decent profitability rating, which may justify a higher PE ratio.

A Closer Look at Profitability for NASDAQ:JAZZ

ChartMill utilizes a Profitability Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of profitability ratios and margins, both in absolute terms and in comparison to industry peers. NASDAQ:JAZZ has earned a 7 out of 10:

With an excellent Return On Assets value of 3.78%, JAZZ belongs to the best of the industry, outperforming 85.94% of the companies in the same industry.
JAZZ has a Return On Equity of 11.10%. This is amongst the best in the industry. JAZZ outperforms 89.58% of its industry peers.
JAZZ has a better Return On Invested Capital (4.95%) than 81.25% of its industry peers.
The 3 year average ROIC (3.02%) for JAZZ is below the current ROIC(4.95%), indicating increased profibility in the last year.
JAZZ has a better Profit Margin (11.60%) than 87.50% of its industry peers.
With an excellent Operating Margin value of 17.62%, JAZZ belongs to the best of the industry, outperforming 85.42% of the companies in the same industry.
The Gross Margin of JAZZ (89.37%) is better than 93.23% of its industry peers.

How We Gauge Health for NASDAQ:JAZZ

A critical element of ChartMill's stock evaluation is the Health Rating, which spans from 0 to 10. This rating considers multiple health factors, including liquidity and solvency, both in absolute terms and relative to industry peers. NASDAQ:JAZZ has received a 6 out of 10:

The Altman-Z score of JAZZ (1.52) is better than 63.02% of its industry peers.
Looking at the Debt to FCF ratio, with a value of 5.55, JAZZ belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
JAZZ has a Current Ratio of 4.26. This indicates that JAZZ is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 4.26, JAZZ is doing good in the industry, outperforming 63.54% of the companies in the same industry.
A Quick Ratio of 3.74 indicates that JAZZ has no problem at all paying its short term obligations.
With a decent Quick ratio value of 3.74, JAZZ is doing good in the industry, outperforming 61.98% of the companies in the same industry.

A Closer Look at Growth for NASDAQ:JAZZ

ChartMill assigns a proprietary Growth Rating to each stock. The score is computed by evaluating various growth aspects, like EPS and revenue growth. We take into account the history as well as the estimated future numbers. NASDAQ:JAZZ was assigned a score of 5 for growth:

JAZZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.22%, which is quite impressive.
Measured over the past years, JAZZ shows a quite strong growth in Revenue. The Revenue has been growing by 15.19% on average per year.

More Decent Value stocks can be found in our Decent Value screener.

Check the latest full fundamental report of JAZZ for a complete fundamental analysis.

Keep in mind

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.